Towards a self-adjuvanting multivalent B and T cell epitope containing synthetic glycolipopeptide cancer vaccine. (Q40023040)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205167%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Towards a self-adjuvanting multivalent B and T cell epitope containing synthetic glycolipopeptide cancer vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205167%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205167%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Pascal Dumy

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205167%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

2

Lbachir BenMohamed

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205167%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

4

Ilham Bettahi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205167%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

3

Gargi Dasgupta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205167%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

1 reference

1 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205167%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205167%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205167%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205167%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

737-741

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205167%20AND%20SRC:MED&resulttype=core&format=json

Tumor-Associated Carbohydrate Antigens

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Carbohydrate antigens as targets for active specific immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines Frequently used abbreviations are listed in the appendix

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Carbohydrate vaccines as immunotherapy for cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Challenges facing adjuvants for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and bovine serum albumin

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Preparation of a multiple antigen glycopeptide (MAG) carrying the Tn antigen. A possible approach to a synthetic carbohydrate vaccine.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Design of peptide-based vaccines for cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Th-cytotoxic T-lymphocyte chimeric epitopes extended by Nepsilon-palmitoyl lysines induce herpes simplex virus type 1-specific effector CD8+ Tc1 responses and protect against ocular infection

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Lipopeptide vaccines--yesterday, today, and tomorrow

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Towards a Fully Synthetic Carbohydrate-Based Anticancer Vaccine: Synthesis and Immunological Evaluation of a Lipidated Glycopeptide Containing the Tumor-Associated Tn Antigen

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Robust immune responses elicited by a fully synthetic three-component vaccine

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Synthetic peptide conjugates—tailor-made probes for the biology of protein modification and protein processing

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Synthesis and medical applications of oligosaccharides

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Tandem peptide ligation for synthetic and natural biologicals.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Chemoselective ligation and antigen vectorization

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

One-Pot Synthesis of Antigen-Bearing, Lysine-Based Cluster Mannosides Using Two Orthogonal Chemoselective Ligation Reactions This work was financially supported by the ANRS and the Fondation pour la Recherche Médicale (Sidaction grant to CG). We are

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Synthesis of branched oxime-linked peptide mimetics of the MUC1 containing a universal T-helper epitope

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Chemoselectively Template-Assembled Glycoconjugates as Mimics for Multivalent Presentation of Carbohydrates

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

On-bead synthesis and binding assay of chemoselectively template-assembled multivalent neoglycopeptides

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Solid-phase-mediated peptide heterodisulfide formation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Exact prediction of a natural T cell epitope

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700315

7 January 2021

Identifiers

DOI

10.1002/CMDC.200700315

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205167%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference